5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.10%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.19%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-33.22%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-33.22%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-59.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-66.67%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-66.67%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
22.73%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
22.73%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Dividend reduction while VALMT.HE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
335.14%
OCF growth above 1.5x VALMT.HE's 200.00%. David Dodd would confirm a clear edge in underlying cash generation.
-2119.05%
Negative FCF growth while VALMT.HE is at 85.71%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-28.51%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-28.51%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-31.50%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-88.58%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 236.82%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-88.58%
Negative 5Y OCF/share CAGR while VALMT.HE is at 236.82%. Joel Greenblatt would question the firm’s operational model or cost structure.
-43.90%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 236.82%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
108.33%
Positive 10Y CAGR while VALMT.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
108.33%
Positive 5Y CAGR while VALMT.HE is negative. John Neff might view this as a strong mid-term relative advantage.
-82.89%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-26.01%
Negative 3Y equity/share growth while VALMT.HE is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.05%
Firm’s AR is declining while VALMT.HE shows 2.89%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.65%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-15.67%
Negative asset growth while VALMT.HE invests at 2.33%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-17.87%
We have a declining book value while VALMT.HE shows 37.01%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-29.46%
We’re deleveraging while VALMT.HE stands at 44.65%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-0.64%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.